Market

Home / Market

Market size for Oxy-Rx™


Product Code
Indication
Registration Classification
Market Size
[m-HPAOC001.5]

Organ Sustainability and Protection ​

(Universal functional fluid and recycle)​

Medical Device

US $10b

[m-HPAOC001.6]​

Brain Injury Protection ​

(Treatment for stroke and traumatic brain injury)​

Human

US $15b

[m-HPAOC001.7]​

Triple Negative Breast Cancer Metastasis​

Human

US $0.5b

[m-HPAOC001.8]​

Brain Tumor Metastasis​

Human

US $2b

[m-HPAOC001.9]​

COVID 19 (ARDS)

Human

US $500b*

*The cost of hospitilizations, on top of any other required treatments for COVID-19, could total $546.6 billion for payers.

https://www.healthcarefinancenews.com/news/average-cost-hospital-care-covid-19-ranges-51000-78000-based-age​

Market size for Oxy-Rx™ pipeline (<1yr possible-DEV)

(US only, research available for large "ethical market" with better outcomes (published)


Indication
Registration Classification
Market Size

Oxygen Availability Protection-for-Perfusion Therapy and Anti-Ischemia/hypoxia/necrosis Treatment ​

Ex. Trauma, Heart attack and stroke resuscitation, ​

Thalassemia and sickle cell crisis,​

Bleeding and anemia

Human / Vet

US $40b

Organ Sustainability and Protection - ​

(Universal functional fluid and recycle)

Medical Device

US $10b

Cancer Metastasis​

Human / Vet

US $2.5b

Veterinary Market

(US only, research available for large "ethical market" with better outcomes (published)


Animal Application (no product in the market)​

For dogs, cats, horses, and companion animals​.

INDEX: Adrenalectomy in Ferrets ​

A common disorder that typically requires sacrifice of another companion ferret in order to replace blood loss during the curative surgery. 

MUMS (Minor Use/ Minor Species): Autoimmune Hemolytic Anemia​

Increasing in prevalence in older dogs where treatment is more difficult and surgical complications more common. The need for transplantation is important for the survival of the dog. ​

Strategic Advantage in prioritizing the veterinary market​

  • No risk, no competition​
  • Confirmation of technology​
  • Strategic partnerships​
  • Viable cost - $100 USD minimum charge per application ​
  • Sizable market - can address a 5% to 10% US animal market of 112 million animals

For further information on OXY-Rx™ please contact us.

We would be happy to discuss it further.

0207 034 3300

We’d like to hear from you

Fitzrovia Hospital,

13-14 Fitzroy Square London, W1T 6AH

Please write to us

Contact us for further information

About

Matinicus Pharma provides life-sustaining support and resuscitation for local (tissue, organ) and systemic (body) oxygen deprivation.


Contact

0207 034 3300


Fitzrovia Hospital,

13-14 Fitzroy Square London, W1T 6AH